Ống thông tiêu sợi huyết Viper ULTRA

MỘT siêu ống thông truyền dịch chuyên dụng cho trực tiếp cung cấp thuốc tiêu sợi huyết, có đặc điểm nhiều lỗ thiết kế để phân phối thuốc đồng đều trên các đoạn cục máu đông lớn.

Các Viper® Ultrasonic Pharmacomechanical Thrombolysis System là một ít xâm lấn device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrinincreasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complicationspreserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

Thông số kỹ thuật sản phẩm

Đặc điểm kỹ thuật Chi tiết / Giá trị
Tên sản phẩm Ống thông tiêu sợi huyết Viper ULTRA
Mục đích sử dụng Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Thiết kế ống thông Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Vật liệu Pebax/Polyamide shaft, potentially braided or reinforced
Đường kính ngoài (F) ~4–6F (depending on infusion lumen capacity)
Chiều dài làm việc ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Khả năng tương thích của Guidewire Typically 0.014” or 0.018”
Vô sinh Vô trùng, sử dụng một lần
Hạn sử dụng ~2–3 years if stored at 15–25 °C in sealed packaging
Chỉ định lâm sàng Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Chống chỉ định Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Ma trận đặt hàng và kích thước

Đường kính ngoài (F) Chiều dài làm việc (cm) Infusion Segment (cm) Mã sản phẩm Ghi chú
Tầng 4 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
Tầng 4 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
Tầng 5 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
Tầng 5 120 20 VPR-5F-120-20 Extended length with longer infusion zone
Tầng 6 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
Tầng 6 150 30 VPR-6F-150-30 Max length, extensive infusion segment